search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    AbbVie Inc.

    (NYSE:ABBV)

    $153.93

    $0.13

    0.08%

    AbbVie Inc. Chart

    ABBV Stock Price Today

    AbbVie Inc. (ABBV) stock rallied over 0.08% intraday to trade at $153.93 a share on NYSE. The stock opened with a gain of 0.56% at $151.9 and touched an intraday high of $154.05, rising 0.08% against the last close of $153.8. The stock went to a low of $149.68 during the session.

    Stock Snapshot

    $153.8

    Prev. Close

    270.65 Billion

    Market Cap

    $149.68

    Day Low

    $151.9

    Open

    1.77 Billion

    Number of Shares

    $154.05

    Day High

    22.06

    P/E ratio

    6.97

    EPS (TTM)

    5.56

    Cash Flow per Share

    0.77

    Free Float in %

    7.66

    Book Value

    5,453,545

    Volume

    AbbVie Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-05$151.9$154.05$149.68$153.934,010,267
    2022-07-01$153.08$153.86$151.46$153.84,619,700
    2022-06-30$153.17$154.04$150.87$153.167,289,500
    2022-06-29$153.9$156.62$153.35$154.146,140,900
    2022-06-28$153.17$155.12$151.39$152.495,735,700
    2022-06-27$153$155.45$152.75$153.145,377,300
    2022-06-24$150.89$152.74$149.62$152.348,527,600
    2022-06-23$148.72$150.8$147.54$149.457,795,000
    2022-06-22$143.72$150.1$143.61$147.567,995,700
    2022-06-21$139.95$143.97$139.7$143.477,160,500

    Contact Details

    1 North Waukegan Road
    North Chicago, IL 60064-6400
    United States

    Webiste:ABBV

    847 932 7900

    Company Information

    Employees-

    Beta0.75

    Sales or Revenue56.73 Billion

    5Y Sales Change17.00%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

    Frequently Asked Questions

    icon

    What is the current AbbVie Inc. (ABBV) stock price?

    AbbVie Inc. (NYSE: ABBV) stock price is $153.93 as of the last check on Tuesday, July 5. During the trading session, ABBV stock reached the peak price of $154.05 while $149.68 was the lowest point it dropped to.

    icon

    ABBV's industry and sector of operation?

    The NYSE listed ABBV is part of Biotechnology industry that operates in the broader Health Care sector. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.

    icon

    Who are the executives of ABBV?

    Ms. Carrie C. Strom
    Sr. VP of AbbVie & Pres of Global Allergan Aesthetics
    Mr. Richard A. Gonzalez
    Chairman & CEO
    Dr. Michael E. Severino M.D.
    Vice Chairman & Pres
    Mr. Robert A. Michael
    Vice Chairman of Fin. & Commercial Operations and CFO

    icon

    What is the ABBV stock price today?

    ABBV stock traded closed the last session at $153.93, which is $0.13 or 0.08% lower than its previous close of $153.8. ABBV's current trading price is 45.82% lower than its 52-week high of $175.91 where as its distance from 52-week low of 105.56% is -12.50%.

    icon

    How many employees does ABBV have?

    Number of ABBV employees currently stands at -. ABBV operates from 1 North Waukegan Road, North Chicago, IL 60064-6400, United States.

    icon

    Link for ABBV official website?

    Official Webiste of $ABBV is: https://www.abbvie.com

    icon

    How do I contact ABBV?

    ABBV could be contacted at ABBV operates from 1 North Waukegan Road, North Chicago, IL 60064-6400, United States, or at phone #847 932 7900 and can also be accessed through its website.

    icon

    How many shares of ABBV are traded daily?

    ABBV stock volume for the day was 5,453,545 shares while in the previous session number of ABBV shares traded was 4,010,267 . The average number of ABBV shares traded daily for last 3 months was 7.32 Million.

    icon

    How much did ABBV change today?

    The percentage change in ABBV stock occurred in the recent session was 0.08% while the dollar amount for the price change in ABBV stock was $0.13.

    icon

    What price range ABBV stock been trading in?

    In the recent session, the day high for ABBV stock was $154.05 while the low for ABBV stock touched on the day was $149.68.

    icon

    What is the market cap of ABBV currently?

    The market value of ABBV currently stands at 270.65 Billion with its latest stock price at $153.93 and 1.77 Billion of its shares outstanding.